News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Brecon Pharmaceuticals Expands Capacity With Significant Investment in New Storage and Distribution Facility



2/7/2012 9:49:09 AM

Herefordshire, UK (07 February 2012) Commercial packaging and clinical trials services specialist Brecon Pharmaceuticals announces the expansion of its storage and distribution capacity, with investment in a state-of-the-art, purpose-built facility in South Wales, UK. Responding to customer demand the new site will provide a further 23,000 square feet of temperature-controlled storage facilities and eight dispatch lanes.

The investment in the new site is part of the company’s ambitious growth strategy and demonstrates its commitment to growing and innovating to meet the changing needs of the pharmaceutical and bio-technology sectors. Enabling even faster turnaround times and access to a broader range of services, the facility at Treforest is strategically located to facilitate access to all major UK airports and road networks - guaranteeing 24-hour national and efficient worldwide distribution.

“Brecon is focused on the rapidly-changing needs of the industries in which we operate and is expanding capacity and innovating services to meet our clients’ needs,” said Peter Belden, Managing Director. “This latest temperature-controlled addition has been designed to meet the highest standards in clinical trial and commercial product handling including the ability to manage ambient, cold and frozen conditions.”

Brecon Pharmaceuticals and its sister company in the United States, Anderson Packaging, supports clients from the earliest stage of R&D through clinical trial and filing and on to commercialisation, packaging and supply. It works with a wide range of clients from small, ‘virtual’ companies through to the biggest global pharmaceutical organisations. “This latest investment demonstrates our commitment to providing our customers with a seamless global offering,” continues Belden, “The additional storage capacity and eight dispatch lanes at the new facility means that we can facilitate the growth we are anticipating both in terms of volume and increasingly complex specifications. With a fully-scalable service we are able to work collaboratively with our customers to support them through the entire drug lifecycle.” The extended capacity builds on the strengthening harmonisation between Brecon Pharmaceuticals and Anderson Packaging of Illinois, USA, both wholly owned by one of the world’s largest pharmaceutical services companies, AmerisourceBergen Corporation.

The Anderson-Brecon alliance enjoys a long and proven track record in delivering unmatched expertise in clinical to commercialisation services and is FDA, MHRA and ISO audited. It employs 1,700 professional and experienced staff including a number of Qualified Persons to support the compliance and auditing process.

About Brecon Pharmaceuticals

Founded in 1980, Brecon Pharmaceuticals is acknowledged as one of the leading outsourced-service providers in the global pharmaceutical industry. With unparalleled expertise in clinical trials supplies management and packing of solid dose forms into blisters, strips, wallets, bottles or sachets, backed by full in-house analytical services, Brecon is the preferred partner of the global pharmaceutical community. The company’s purpose-built facilities in Hay-on-Wye, Herefordshire, are the best-equipped and most modern in the UK.

Since 2006 Brecon has been a business of AmerisourceBergen Corporation. AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With $80 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 10,000 people. AmerisourceBergen is ranked #27 on the Fortune 500 list. Brecon works closely with its AmerisourceBergen sister company Anderson Packaging (Rockford, IL) to deliver harmonised services in Europe, the Americas and beyond.

For further information please visit www.breconpharm.com

For further press information please contact: Michelle Valentine, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA, United Kingdom Tel: + 44 1477 539539 Fax: +44 1477 539 540 E-mail: brecon@scottpr.com


Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES